Delequamine
Chemical compound
| Delequamine | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Delequamine is a chemical compound that has been studied for its potential use in various medical applications. It is classified as a phenethylamine derivative and is structurally related to other compounds in this class.
Chemical Structure[edit | edit source]
Delequamine is characterized by its phenethylamine backbone, which is a common structural motif in many biologically active compounds. The chemical structure of Delequamine includes a 2,3-dimethoxyphenyl group attached to a methylamino propanone moiety. This structure is depicted in the accompanying image.
Pharmacology[edit | edit source]
The pharmacological properties of Delequamine are of interest due to its potential effects on the central nervous system. As a phenethylamine derivative, it may interact with various neurotransmitter systems, although specific receptor targets and mechanisms of action have not been fully elucidated.
Potential Applications[edit | edit source]
Research into Delequamine has explored its potential applications in the treatment of certain medical conditions. However, as of the latest updates, it remains primarily a compound of research interest rather than a clinically approved medication.
Synthesis[edit | edit source]
The synthesis of Delequamine involves the chemical modification of the phenethylamine core. The process typically includes the introduction of methoxy groups to the phenyl ring and the formation of the methylamino propanone side chain. Detailed synthetic pathways are documented in chemical literature for those interested in the laboratory preparation of this compound.
Safety and Toxicology[edit | edit source]
As with many research chemicals, the safety profile of Delequamine is not fully established. Studies on its toxicity, potential side effects, and safe dosage ranges are necessary before any consideration for clinical use.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
